← Back to Search

Intention Treatment for Aphasia

N/A
Recruiting
Led By Amy D. Rodriguez, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of word retrieval deficits
Diagnosis of aphasia
Must not have
Severe apraxia of speech or dysarthria
Clinically significant depression
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months; change from baseline to 3 weeks (post massed-int) or 12 weeks (post distributed-int), change at 3 months post-treatment, change at 6 months post-treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is investigating a new word retrieval treatment for Veterans with aphasia caused by stroke, to see if it is more effective than the current standard of care.

Who is the study for?
This trial is for Veterans who primarily speak English, have aphasia with difficulty finding words after a stroke in the left side of the brain, and can follow two-step commands. It's not for those with implanted medical devices or metal in their bodies, severe speech muscle control issues, or major depression.
What is being tested?
The study tests a new word retrieval treatment for aphasia following a stroke. Researchers aim to find out how intense this therapy should be and what factors predict success in improving language skills among Veterans.
What are the potential side effects?
Since this is a non-drug intervention focusing on language therapy post-stroke, traditional medication side effects are not expected. However, participants may experience fatigue or frustration during intensive language exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I struggle to find the right words when speaking.
Select...
I have been diagnosed with aphasia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe difficulty speaking clearly.
Select...
I have been diagnosed with severe depression.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study study completion, an average of 6 months; change from baseline to 3 weeks (post m-int) or 12 weeks (post d-int), change at 3 months post-treatment, change at 6 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study study completion, an average of 6 months; change from baseline to 3 weeks (post m-int) or 12 weeks (post d-int), change at 3 months post-treatment, change at 6 months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Boston Naming Test
Brief Visuospatial Memory Test-Revised
Delis?Kaplan Executive Function System (D-KEFS) Sorting
+8 more
Secondary study objectives
Delis?Kaplan Executive Function System (D-KEFS) Trails

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Distributed Intention Treatment (distributed-INT)Active Control1 Intervention
Participants will receive 30 hours of Intention Treatment (INT) over 12 weeks.
Group II: Massed Intention Treatment (massed-INT)Active Control1 Intervention
Participants will receive 30 hours of Intention Treatment (INT) over 3 weeks.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,248 Total Patients Enrolled
Amy D. Rodriguez, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
2 Previous Clinical Trials
41 Total Patients Enrolled

Media Library

Intention Treatment for Anomia Clinical Trial Eligibility Overview. Trial Name: NCT04267198 — N/A
Hemoglobinopathy Research Study Groups: Distributed Intention Treatment (distributed-INT), Massed Intention Treatment (massed-INT)
Hemoglobinopathy Clinical Trial 2023: Intention Treatment for Anomia Highlights & Side Effects. Trial Name: NCT04267198 — N/A
Intention Treatment for Anomia 2023 Treatment Timeline for Medical Study. Trial Name: NCT04267198 — N/A
~3 spots leftby Mar 2025